Immune checkpoints in antitumor response: a potential antitumor immunotherapy

PD-1/PD-L1 checkpoint. The action mechanism begins when T cells are activated upon recognition of the antigen presented in HLA-I, triggering a signaling cascade and the release of cytokines that activate their proliferation. (A) In a normal microenvironment, after T cell activation and proliferation, immune checkpoint proteins, such as PD-1 and its ligand PDL-1, are expressed that prevent their excessive activation. (B) In a tumor microenvironment, the expression of immune checkpoints favors escape from immunosurveillance. Once T cells recognize the tumor antigen presented in HLA-I, they are activated and produce IFN-γ that binds to the IFN-γ receptor, inducing PD-L1 overexpression in tumor cells. PD-L1 binds to PD-1, which is overregulated in T cells, and thus inhibits the immune response. (C) PD-L1 can interact with CD80/CD86 on the antigen-presenting cell (APC) and disrupt PD-L1/PD-1 binding. It has been documented that CD80/CD86 are not only expressed on APCs but also on T cells, suggesting that it may be another pathway in T cells that may serve to downregulate responses and prevent T cell signals. (D) Anti-PD-1 antibody or anti-PD-L1 blocks the interaction of PD-1 and PD-L1 and suppresses the inhibition of CD8+ T cells, thereby enhancing antitumor activity.
Immune checkpoints in antitumor response: a potential antitumor immunotherapy

Publication

The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy. (2023) Lidy Vannessa Mejía-Guarnizo, et al. Front Immunol. 2023;14:1298571. Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates CD8 CD8 ncbigene_synonym CD8A 925
Homo sapiens Primates CD8 CD8 famplex_relations CD8B 926
Homo sapiens Primates PD-L1 PD-L1 ncbigene_synonym CD274 29126
Homo sapiens Primates PD-1 PD-1 ncbigene_synonym PDCD1 5133
Homo sapiens Primates PD-1 PD-1 ncbigene_synonym RPL17 6139
Homo sapiens Primates PD-1 PD-1 ncbigene_synonym RPL17-C18orf32 100526842
Homo sapiens Primates TCR TCR ncbigene_synonym TRBV20OR9-2 6962
Homo sapiens Primates TCR TCR famplex_relations TRA 6955
Homo sapiens Primates TCR TCR famplex_relations TRB 6957
Homo sapiens Primates TCR TCR famplex_relations TRD 6964
Homo sapiens Primates TCR TCR famplex_relations TRG 6965
Homo sapiens Primates CD28 CD28 ncbigene_symbol CD28 940
Homo sapiens Primates CD80 CD80 ncbigene_symbol CD80 941
Homo sapiens Primates CD86 CD86 ncbigene_symbol CD86 942
Homo sapiens Primates JAK1/2 JAK2 ncbigene_symbol JAK2 3717
Homo sapiens Primates JAK1/2 JAK1 ncbigene_symbol JAK1 3716
Homo sapiens Primates JAK JAK famplex_relations JAK3 3718
Homo sapiens Primates JAK JAK famplex_relations TYK2 7297
Homo sapiens Primates STAT1 STAT1 ncbigene_symbol STAT1 6772
Homo sapiens Primates STAT STAT ncbigene_synonym SOAT1 6646
Homo sapiens Primates STAT STAT famplex_relations STAT2 6773
Homo sapiens Primates STAT STAT famplex_relations STAT3 6774
Homo sapiens Primates STAT STAT famplex_relations STAT4 6775
Homo sapiens Primates STAT STAT famplex_relations STAT6 6778
Homo sapiens Primates STAT STAT famplex_relations STAT5A 6776
Homo sapiens Primates STAT STAT famplex_relations STAT5B 6777
Homo sapiens Primates APC APC ncbigene_symbol APC 324
Homo sapiens Primates APC APC ncbigene_synonym PROC 5624
Homo sapiens Primates IRF1 IRF1 ncbigene_symbol IRF1 3659

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID